Français
Search this site:
Symbol
Last
Change
IPN.PA
26.00 €
(-1.52 % )
powered by Euronext©
The Group
Profile & Key figures
Message from the Chairman
Group history
R & D
R & D Homepage
Neurology
Endocrinology
Uro-Oncology
Medicines
Governance
Board of directors
Board committees
Leadership
Compensation of corporate officers
Business Development & Alliance Management
Ipsen worldwide
Targeted diseases
Neurology
Endocrinology
Uro-oncology
Primary care
Commitments
Vision, mission and action principles
Environment, health and safety
Ethics and compliance
Support to Patient Organizations
Corporate Citizenship
Fondation IPSEN
La Fondation Ipsen at a glance
Colloques, prizes, publications
Neurosciences
Alzheimer’s disease
Endocrinology
Cancer science
Longevity
Vascular
Partnerships
Salk Institute - Nature
Cell Press - DMM Global Foundation
Nature Publishing Group
Home
>
News list
> February 27, 2013: Full year 2012 results
Previous news
Next news
News list
February 27, 2013: Full year 2012 results
16 January 2013
Go to
Press room
Investor relations
Careers
